Stefano Ruga, Raffaele Petti, Mara Masullo, Fabio Castagna, Roberto Bava, Michelangelo Armenise, Elisabetta Labbate, Carmen Lombardi, Antonio Giordano, Massimiliano Quintiliani, Luigi Alfano, Emilia Langella, Giovanna Liguori, Renato Lombardi
{"title":"The Phenomenon of Antimicrobial Resistance in Southern Italy: An Overview of the Current Situation.","authors":"Stefano Ruga, Raffaele Petti, Mara Masullo, Fabio Castagna, Roberto Bava, Michelangelo Armenise, Elisabetta Labbate, Carmen Lombardi, Antonio Giordano, Massimiliano Quintiliani, Luigi Alfano, Emilia Langella, Giovanna Liguori, Renato Lombardi","doi":"10.34172/apb.025.45467","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Antimicrobial resistance (AMR) is an escalating global health challenge with region-specific implications. This study investigated AMR prevalence in Southern Italy, with particular attention to demographic variables such as gender and age.</p><p><strong>Methods: </strong>A retrospective analysis of antibiograms from 146 patients (68 males and 78 females, aged 36-101 years) collected between 2022 and 2023 was conducted. Given the retrospective design and reliance on routinely collected clinical data from a local hospital microbiology laboratory, molecular analyses were not feasible, as isolates were processed solely for diagnostic purposes and not preserved.</p><p><strong>Results: </strong>The most frequently isolated pathogens were <i>Escherichia coli</i> (52.3%), <i>Klebsiella pneumoniae</i> (14.9%), <i>Enterococcus faecalis</i> (6.9%), <i>Proteus mirabilis</i> (6.3%), <i>Staphylococcus aureus</i> (4.6%), and <i>Pseudomonas aeruginosa</i> (4.3%). In males, the highest resistance rates were recorded for ciprofloxacin (47.9%), levofloxacin (47.2%), and trimethoprim/sulfamethoxazole (40.5%). Female patients showed greater resistance to amoxicillin/clavulanate, levofloxacin, and trimethoprim/sulfamethoxazole, with women≥70 years displaying particularly elevated resistance compared with age-matched men and younger females.</p><p><strong>Conclusion: </strong>Despite the absence of molecular data, phenotypic surveillance through antibiograms remains a critical tool for monitoring AMR trends in underrepresented regions. Incorporating gender-specific differences into clinical practice may improve therapeutic efficacy and stewardship strategies. These findings provide a foundation for future molecular and epidemiological investigations.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"15 4","pages":"871-882"},"PeriodicalIF":4.7000,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12980278/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced pharmaceutical bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/apb.025.45467","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Antimicrobial resistance (AMR) is an escalating global health challenge with region-specific implications. This study investigated AMR prevalence in Southern Italy, with particular attention to demographic variables such as gender and age.
Methods: A retrospective analysis of antibiograms from 146 patients (68 males and 78 females, aged 36-101 years) collected between 2022 and 2023 was conducted. Given the retrospective design and reliance on routinely collected clinical data from a local hospital microbiology laboratory, molecular analyses were not feasible, as isolates were processed solely for diagnostic purposes and not preserved.
Results: The most frequently isolated pathogens were Escherichia coli (52.3%), Klebsiella pneumoniae (14.9%), Enterococcus faecalis (6.9%), Proteus mirabilis (6.3%), Staphylococcus aureus (4.6%), and Pseudomonas aeruginosa (4.3%). In males, the highest resistance rates were recorded for ciprofloxacin (47.9%), levofloxacin (47.2%), and trimethoprim/sulfamethoxazole (40.5%). Female patients showed greater resistance to amoxicillin/clavulanate, levofloxacin, and trimethoprim/sulfamethoxazole, with women≥70 years displaying particularly elevated resistance compared with age-matched men and younger females.
Conclusion: Despite the absence of molecular data, phenotypic surveillance through antibiograms remains a critical tool for monitoring AMR trends in underrepresented regions. Incorporating gender-specific differences into clinical practice may improve therapeutic efficacy and stewardship strategies. These findings provide a foundation for future molecular and epidemiological investigations.